» Articles » PMID: 28445557

US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013

Overview
Journal JAMA Psychiatry
Specialty Psychiatry
Date 2017 Apr 27
PMID 28445557
Citations 190
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: Over the last 25 years, illicit cannabis use and cannabis use disorders have increased among US adults, and 28 states have passed medical marijuana laws (MML). Little is known about MML and adult illicit cannabis use or cannabis use disorders considered over time.

Objective: To present national data on state MML and degree of change in the prevalence of cannabis use and disorders.

Design, Participants, And Setting: Differences in the degree of change between those living in MML states and other states were examined using 3 cross-sectional US adult surveys: the National Longitudinal Alcohol Epidemiologic Survey (NLAES; 1991-1992), the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC; 2001-2002), and the National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III; 2012-2013). Early-MML states passed MML between NLAES and NESARC ("earlier period"). Late-MML states passed MML between NESARC and NESARC-III ("later period").

Main Outcomes And Measures: Past-year illicit cannabis use and DSM-IV cannabis use disorder.

Results: Overall, from 1991-1992 to 2012-2013, illicit cannabis use increased significantly more in states that passed MML than in other states (1.4-percentage point more; SE, 0.5; P = .004), as did cannabis use disorders (0.7-percentage point more; SE, 0.3; P = .03). In the earlier period, illicit cannabis use and disorders decreased similarly in non-MML states and in California (where prevalence was much higher to start with). In contrast, in remaining early-MML states, the prevalence of use and disorders increased. Remaining early-MML and non-MML states differed significantly for use (by 2.5 percentage points; SE, 0.9; P = .004) and disorder (1.1 percentage points; SE, 0.5; P = .02). In the later period, illicit use increased by the following percentage points: never-MML states, 3.5 (SE, 0.5); California, 5.3 (SE, 1.0); Colorado, 7.0 (SE, 1.6); other early-MML states, 2.6 (SE, 0.9); and late-MML states, 5.1 (SE, 0.8). Compared with never-MML states, increases in use were significantly greater in late-MML states (1.6-percentage point more; SE, 0.6; P = .01), California (1.8-percentage point more; SE, 0.9; P = .04), and Colorado (3.5-percentage point more; SE, 1.5; P = .03). Increases in cannabis use disorder, which was less prevalent, were smaller but followed similar patterns descriptively, with change greater than never-MML states in California (1.0-percentage point more; SE, 0.5; P = .06) and Colorado (1.6-percentage point more; SE, 0.8; P = .04).

Conclusions And Relevance: Medical marijuana laws appear to have contributed to increased prevalence of illicit cannabis use and cannabis use disorders. State-specific policy changes may also have played a role. While medical marijuana may help some, cannabis-related health consequences associated with changes in state marijuana laws should receive consideration by health care professionals and the public.

Citing Articles

The relationship of medical and recreational cannabis laws with opioid misuse and opioid use disorder in the USA: Does it depend on prior history of cannabis use?.

Martins S, Bruzelius E, Mauro C, Santaella-Tenorio J, Boustead A, Wheeler-Martin K Int J Drug Policy. 2025; 136:104687.

PMID: 39793270 PMC: 11821435. DOI: 10.1016/j.drugpo.2024.104687.


Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning.

Jayawardhana J, Hou J, Freeman P, Talbert J JAMA Psychiatry. 2024; 82(3):228-236.

PMID: 39714863 PMC: 11883495. DOI: 10.1001/jamapsychiatry.2024.4145.


Cannabis Use and Cannabis Use Disorder Among U.S. Adults with Psychiatric Disorders: 2001-2002 and 2012-2013.

Hasin D, Mannes Z, Livne O, Fink D, Martins S, Stohl M Subst Use Misuse. 2024; 60(2):285-292.

PMID: 39533528 PMC: 11710973. DOI: 10.1080/10826084.2024.2423374.


Cannabis Vaping Among US Adults With Disabilities: Findings From the 2022 Behavioral Risk Factor Surveillance System.

Olufemi E, Olatokunbo O, Wei L, Ben Taleb Z, Ebrahimi Kalan M Public Health Rep. 2024; :333549241292447.

PMID: 39513335 PMC: 11556670. DOI: 10.1177/00333549241292447.


Historical change in associations between perceived risk, disapproval, and use of cannabis among young adults ages 19-30, 2011-2022.

Terry-McElrath Y, Pang Y, Patrick M Addict Behav. 2024; 160:108185.

PMID: 39388852 PMC: 11844231. DOI: 10.1016/j.addbeh.2024.108185.


References
1.
Vrasti R, Grant B, Chatterji S, Ustun B, Mager D, Olteanu I . Reliability of the Romanian version of the alcohol module of the WHO Alcohol Use Disorder and Associated Disabilities: Interview Schedule --Alcohol/Drug-Revised. Eur Addict Res. 1998; 4(4):144-9. DOI: 10.1159/000018947. View

2.
Rubio J, Olfson M, Villegas L, Perez-Fuentes G, Wang S, Blanco C . Quality of life following remission of mental disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2013; 74(5):e445-50. DOI: 10.4088/JCP.12m08269. View

3.
Jordan B, Karg R, Batts K, Epstein J, Wiesen C . A clinical validation of the National Survey on Drug Use and Health assessment of substance use disorders. Addict Behav. 2008; 33(6):782-98. DOI: 10.1016/j.addbeh.2007.12.007. View

4.
Martins S, Keyes K, Storr C, Zhu H, Grucza R . Birth-cohort trends in lifetime and past-year prescription opioid-use disorder resulting from nonmedical use: results from two national surveys. J Stud Alcohol Drugs. 2010; 71(4):480-7. PMC: 2887918. DOI: 10.15288/jsad.2010.71.480. View

5.
Schuermeyer J, Salomonsen-Sautel S, Price R, Balan S, Thurstone C, Min S . Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003-11. Drug Alcohol Depend. 2014; 140:145-55. PMC: 4161452. DOI: 10.1016/j.drugalcdep.2014.04.016. View